IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

List of Oncology Medication For

Lymphoma

The treatment of lymphoma depends on several factors, including the type and stage of the cancer, the patient’s age and overall health, and other individual factors. Treatment options may include: Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Stem cell transplantation.

Indian Pharma Network

M: +9891296838 / 9811747774
E: med@indianpharmanetwork.co.in

pembrolizumab injection

pembrolizumab injection
for intravenous use Initial U.S. Approval: 2014

pembrolizumab is indicated for the treatment of patients with unresectable or metastatic melanoma.

Facts about pembrolizumab injection

DISEASE INDICATIONS-Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer
MANUFACTURER-Merck Sharp & Dohme Corp.
USAGE-intravenous
MEDICINE APPROVED BY- European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “pembrolizumab injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

pirtobrutinib tablets

pirtobrutinib tablets,
For oral use Initial U.S. Approval: 2023

As specified in the prescribing information, pirtobrutinib tablets is indicated for the treatment of Lymphoma cancer disease. As per highlights Of prescribing information pirtobrutinib tablets is kinase inhibitor indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a BTK inhibitor.

Facts about pirtobrutinib tablets

Disease Indications: Lymphoma
Dosage Forms And Strengths: Tablets: 50 mg, 100 mg
Manufacturer: Lilly
Usage: Oral
Medicine Approved By: Food and Drug Administration (FDA)
Jaypirca (pirtobrutinib) was approved by the FDA in the USA in January 2023

Extra Information:

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “pirtobrutinib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

Polatuzumab Vedotin-PIIQ for Injection

polatuzumab vedotin-piiq for injection,
for intravenous use Initial U.S. Approval: 2019

Polatuzumab vedotin-piiq for injection is a “used to treat lymphoma“. POLIVY for injection is a “prescription medicine. It is available in “form and strength” For injection: 140 mg of polatuzumab vedotin-piiq as a lyophilized powder in a single-dose vial. POLIVY for injection can be obtained in India upon request.

To inquire about the “offer price in India”, “shipping process”, and the “estimated time of availability in India”, please get in touch at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj). with the IPN Delhi healthcare team for further discussion.”

Facts about your medicine

Name: POLIVY
Active substance: polatuzumab vedotin-piiq
Therapeutic area: lymphoma
Marketing Authorisation: 2019.
AUTHORISED: Food and Drug Administration (FDA), Pharmaceuticals and Medical Devices Agency (PMDA), Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here for POLIVY usage
(see Drugs@FDA for complete indication)

read more

Pralatrexate Injection

Pralatrexate Injection Solution for intravenous injection Initial U.S. Approval: 2009

Generic Name – Pralatrexate
Medicine Type – Injection
Manufacturer Name – Allos Therapeutics, Inc
Approval Year – 2009
Approved by – Food and Drug Administration (FDA)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import pralatrexate injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

rituximab-abbs injection

rituximab-abbs injection
for intravenous use Initial U.S. Approval: 2018

Truxima (rituximab) is a medication used for the treatment of follicular lymphoma and diffuse large B-cell Non-Hodgkin’s Lymphoma (NHL); chronic lymphocytic leukemia (CLL); severe active rheumatoid arthritis and granulomatosis with polyangiitis and microscopic polyangiitis.

Facts about rituximab-abbs injection

Disease Indications-Leukemia, Lymphoma, Rheumatoid Arthritis, Granulomatosis , Polyangiitis
Manufacturer-Celltrion Healthcare Hungary Kft, Teva Pharmaceuticals
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “rituximab-abbs injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

Romidepsin Injection

romidepsin for injection
For intravenous infusion only Initial US Approval: 2009

ISTODAX is a histone deacetylase (HDAC) inhibitor indicated for: • Treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy

Facts about Romidepsin Injection

Approval Date: 2009
Proprietary Name: On Request
Active Ingredient(s):  Romidepsin Injection
Dosage Forms And Strengths: Injection, 10 mg, supplied with one Diluent vial containing 2 mL (deliverable volume) of solution
Company: Gloucester Pharmaceuticals, Inc
Current indications: cutaneous T-cell lymphoma (CTCL)
Medicine Approved By: –
 European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “Romidepsin Injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

selinexor tablets

selinexor tablets,
for oral use Initial U.S. Approval: 2019

Xpovio (selinexor) is a medication used for the treatment of patients with  relapsed/refractory multiple myeloma or diffuse large B-cell lymphoma. It has been approved by the European Medicines Agency (EMA) under the brand name Nexpovio (selinexor).

Facts about selinexor tablets

Disease Indications-Lymphoma, Multiple Myeloma
Manufacturer-Karyopharm
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “selinexor tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

tafasitamab-cxix for injection

tafasitamab-cxix for injection, for intravenous use Initial U.S. Approval: 2020

Monjuvi (tafasitamab-cxix) is a medication that is combined with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

Facts about tafasitamab-cxix for injection

Disease Indications-Lymphoma
Manufacturer-MorphoSys AG
Usage-Intravenous
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “tafasitamab-cxix for injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

tirabrutinib-tablets

Velexbru Tablet 80mg,
a Bruton’s Tyrosine Kinase Inhibitor in Japan

Velexbru® Tablet 80mg, a BTK Inhibitor, for Additional Indication of  Waldenstrom Macroglobulinemia and Lymphoplasmacytic Lymphoma. Velexbru (tirabrutinib hydrochloride) is a medication used for the treatment of recurrent or refractory primary central nervous system lymphoma.

Facts about tirabrutinib-tablets

Disease Indications-Lymphoma
Manufacturer-Ono Pharmaceutical Co., Ltd.
Usage-Oral
Medicine Approved By-Pharmaceuticals and Medical Devices Agency (PMDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “tirabrutinib-tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

umbralisib tablets

umbralisib tablets
for oral use Initial U.S. Approval: 2021

Ukoniq (umbralisib) is a medication used for the treatment of adult patients with subtypes of Non-Hodgkin Lymphoma, namely relapsed or refractory marginal zone lymphoma (MZL) and relapsed or refractory follicular lymphoma (FL).

Facts about umbralisib tablets

DISEASE INDICATIONS-Lymphoma
MANUFACTURER-TG Therapeutics
USAGE-Oral
MEDICINE APPROVED BY-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “umbralisib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398